TrialCurrent oncology (Toronto, Ont.)2023

A Multi-Centre Randomized Study Comparing Two Standard of Care Chemotherapy Regimens for Lower-Risk HER2-Positive Breast Cancer.

Ricardo Fernandes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.